Efficiency of antimalarial chemoprophylaxis – an analysis of malaria morbidity among members of section for tropical medicine, medical faculty of Ljubljana, on electives in third world countries 1990–2005
Abstract
Background: The aim of this study was to assess the incidence of malaria among the homogenous population of medical students and young doctors, specifically educated in tropical medicine, travelling to the third world countries for electives of two to four months’ duration with professional and humanitarian purposes. We focused on the efficiency of currently widely reccomended antimalarial chemoprophylaxis, especially mefloquine.
Methods: The data were collected by a questionnaire, analysis of medical documentation and medical examinations of elective participants after their return. Malaria was diagnosed either microscopically or on basis of typical clinical features, followed by marked improvement after antimalarial therapy.
Results: From 106 expedition members that were adherent to regular exposure prophylactic measures as well as recommended chemoprophylaxis, 28 (26 %) reported malaria. 23 (82 %) among them visited Africa and 23 (82 %) were taking mefloquine for chemoprophylaxis. None suffered from complicated form of disease. No statistically significant differences in malaria morbidity with reference to travel destination, gender or weather season were found.
Conclusions: High incidence of malaria in our population could be partially explained by a relatively long period of travel in malaria hyperendemic regions. We carefully examined the possibility of erroneous diagnosis of malaria as well as probable increase in mefloquine resistance in hyperendemic rural regions of Africa. Absence of complicated malaria proves the benefits of complete adherence to antimalarial exposure and chemoprophylaxis.
Downloads
References
Dosegljivo na URL: http://www.cdc.org/travel
Kotar T, Pikelj F, ured. Potovalna medicina 3. Zbornik predavanj. Med Razgl 2004; 43 Suppl 3.
Jereb M, Bombek M, Kšela J, Modrica-Kobe J, Muzlovič I, Trampuž A. Zdravljenje težke oblike malarije. Zdrav Vestn 2004; 73: 131–7.
Kotar T. Okužbe in obolevanje slovenskih popotnikov v tropske in subtropske dežele [magistrsko delo]. Ljubljana: Univerza v Ljubljani, 2006.
Dosegljivo na URL: http://www.cdc.gov/malaria/drug_resistance.htm
Dosegljivo na URL: http://www.who.int/drugresistance/malaria/en/
WHO, UNICEF. Roll back malaria. World Malaria Report 2005.
Suh KN, Kain KC, Keystone JS. Malaria. CMAJ 2004; 170: 1693– 702.
Dosegljivo na URL: http://www.stpm.org
Romi R, Boccolini D, Majori G. Malaria in Italy: Incidence and mortality in 1999 and 2000. Eurosurveillance 2001; 6: 143–7.
Shah S, et al. Malaria surveillance – United States, 2002. MMWR 2004;53: 21–36.
Schoeneberg I, et al. Erfassung der Malaria in Deutschland – Daten und Fakten zu den Erkrankungen in Deutschland 2000/ 2001. Uebergang zu einem neuen Meldesystem. Gesundheitswesen 2003; 65: 263–9.
Pasvol G. Malaria. In: Eddleston M, Pierini R, Wilkinson R, Davidson R, eds. Oxford handbook of tropical medicine. 2nd ed. New York: Oxford University Press Inc.; 2005. p. 9–38.
Lang W. Malaria. In: Lang W, ed. Tropenmedizin in Klinik und Praxis. Stuttgart, New York: Georg Thieme Verlag; 1993. p. 7–33.
Causer LM, Filler S, Wilson M, Papagiotos S, Newman RD. Evaluation of reported malaria chemoprophylactic failure among travelers in a US University Exchange Program, 2002. Clin Infect Dis 2004; 39: 1583–8.
Raccurt CP, Dumestre-Toulet V, Abraham E, Le Bras M, Brachet- Liermain A, Ripert C. Failure of falciparum malaria prophylaxis by mefloquine in travelers from West Africa. Am J Trop Med Hyg 1991; 45: 319–24.
Wichmann O, Betschart B, Loscher T, Nothdurft HD, Sonnenbura FV, Jelinek T. Prophylaxis failure due to probable mefloquine resistant P. falciparum from Tanzania. Acta Trop 2003; 86: 63–5.
Fivelman QL, Butcher GA, Adagu IS, Warhurst DC, Pasvol G. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. Malar J 2002; 1: 1.
Farnert A, Lindberg J, Gil P, Swedberg G, Berqvist Y, Thapar MM, et al. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports. BMJ 2003; 326: 628–9.
Lewis SJ, Davidson RN, Ross EJ, Hall AP. Severity of imported falciparum malaria: effect of taking antimalarial prophylaxis. BMJ 1992; 305: 741–3.
Schwartz E, Sadetzki S, Murat H, Raveh D. Age as a risk factor for severe Plasmodium falciparum malaria in nonimmune patients. Clin Inf Dis 2001; 33: 1774–7.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
